HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome.

Abstract
Trans11-18:1 (vaccenic acid, VA) is one of the most predominant naturally occurring trans fats in our food chain and has recently been shown to exert hypolipidemic effects in animal models. In this study, we reveal new mechanism(s) by which VA can alter body fat distribution, energy utilization and dysfunctional lipid metabolism in an animal model of obesity displaying features of the metabolic syndrome (MetS). Obese JCR:LA-cp rats were assigned to a control diet that included dairy-derived fat or the control diet supplemented with 1% VA. VA reduced total body fat (-6%), stimulated adipose tissue redistribution [reduced mesenteric fat (-17%) while increasing inguinal fat mass (29%)] and decreased adipocyte size (-44%) versus control rats. VA supplementation also increased metabolic rate (7%) concomitantly with an increased preference for whole-body glucose utilization for oxidation and increased insulin sensitivity [lower HOMA-IR (-59%)]. Further, VA decreased nonalcoholic fatty liver disease activity scores (-34%) and reduced hepatic (-27%) and intestinal (-39%) triglyceride secretion relative to control diet, while exerting differential transcriptional regulation of SREBP1 and FAS amongst other key genes in the liver and the intestine. Adding VA to dairy fat alleviates features of MetS potentially by remodeling adipose tissue and attenuating ectopic lipid accumulation in a rat model of obesity and MetS. Increasing VA content in the diet (naturally or by fortification) may be a useful approach to maximize the health value of dairy-derived fats.
AuthorsM Miriam Jacome-Sosa, Faye Borthwick, Rabban Mangat, Richard Uwiera, Martin J Reaney, Jianheng Shen, Ariel D Quiroga, René L Jacobs, Richard Lehner, Spencer D Proctor, Randal C Nelson
JournalThe Journal of nutritional biochemistry (J Nutr Biochem) Vol. 25 Issue 7 Pg. 692-701 (Jul 2014) ISSN: 1873-4847 [Electronic] United States
PMID24775093 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Dietary Fats
  • Fatty Acids
  • Insulin
  • Oleic Acids
  • 11-octadecenoic acid
Topics
  • Adipocytes (drug effects)
  • Adipose Tissue (drug effects, metabolism)
  • Animals
  • Dairy Products
  • Dietary Fats (pharmacology)
  • Disease Models, Animal
  • Disease Progression
  • Fatty Acids (pharmacology)
  • Insulin (metabolism)
  • Insulin Resistance
  • Liver (drug effects, metabolism)
  • Male
  • Metabolic Syndrome (metabolism, prevention & control)
  • Non-alcoholic Fatty Liver Disease (physiopathology, prevention & control)
  • Obesity (metabolism)
  • Oleic Acids (pharmacology)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: